輸入代號或公司名稱後按 Enter
4121

優盛

-0.10 (-0.79%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
12.5538成交張數本益比0.74股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20253,800年增 -1.3%
毛利率202534.4%最新一期
營業利益率2025-1.9%最新一期
每股盈餘2025-0.36
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計71.5%69.4%69.2%68.2%66.5%67.2%65.3%66.6%65.3%65.6%
營業毛利(毛損)28.5%30.6%30.8%31.8%33.5%32.8%34.7%33.4%34.7%34.4%
營業毛利(毛損)淨額28.5%30.6%30.8%31.8%33.5%32.8%34.7%33.4%34.7%34.4%
推銷費用24.6%23.1%23.8%24.2%22.8%23.1%22.8%26.4%30.0%29.4%
管理費用6.3%5.7%5.9%5.6%5.2%4.9%4.7%5.7%5.3%5.5%
研究發展費用1.5%1.3%1.4%2.1%1.6%1.4%1.2%1.3%1.3%1.4%
預期信用減損損失(利益)-0.1%-0.0%0.1%0.0%-0.0%-0.0%0.0%
營業費用合計32.4%30.1%31.1%31.8%29.5%29.4%28.7%33.3%36.6%36.3%
營業利益(損失)-3.9%0.5%-0.2%0.0%4.0%3.4%5.9%0.1%-2.0%-1.9%
利息收入0.1%0.1%0.1%0.1%0.1%0.1%
其他收入3.2%1.2%1.4%1.6%1.4%1.1%0.9%0.9%1.2%1.1%
其他利益及損失淨額0.9%-0.2%-0.2%0.3%-0.0%-0.0%-0.1%-0.0%0.1%-0.1%
財務成本淨額0.4%0.3%0.3%0.7%0.6%0.5%0.5%0.7%0.8%0.7%
營業外收入及支出合計3.7%0.7%0.9%1.2%0.9%0.6%0.3%0.3%0.6%0.3%
稅前淨利(淨損)-0.2%1.2%0.7%1.2%4.9%4.0%6.3%0.4%-1.4%-1.6%
所得稅費用(利益)合計0.6%0.5%0.3%0.4%0.7%0.8%1.3%0.4%0.0%0.2%
繼續營業單位本期淨利(淨損)-0.8%0.7%0.4%0.8%4.2%3.2%5.0%0.0%-1.4%-1.8%
本期淨利(淨損)-0.8%0.7%0.4%0.8%4.2%3.2%5.0%0.0%-1.4%-1.8%
確定福利計畫之再衡量數-0.0%0.0%-0.2%-0.0%-0.0%-0.0%0.1%-0.0%-0.0%-0.0%
不重分類至損益之項目:-0.0%-0.0%-0.0%0.1%-0.0%-0.0%-0.0%
國外營運機構財務報表換算之兌換差額-0.6%-0.1%-0.1%-0.3%0.1%-0.1%0.1%-0.2%0.2%-0.0%
後續可能重分類至損益之項目:-0.3%0.1%-0.1%0.1%-0.2%0.2%-0.0%
其他綜合損益(淨額)-0.7%-0.1%-0.3%-0.3%0.1%-0.1%0.2%-0.2%0.1%-0.0%
本期綜合損益總額-1.4%0.6%0.1%0.5%4.2%3.1%5.2%-0.2%-1.3%-1.8%
母公司業主(淨利∕損)0.6%0.9%0.5%0.8%3.7%2.8%3.9%-0.2%-0.8%-0.8%
非控制權益(淨利∕損)-1.4%-0.2%-0.1%-0.1%0.5%0.4%1.1%0.2%-0.7%-1.0%
母公司業主(綜合損益)-0.0%0.8%0.2%0.5%3.8%2.7%4.1%-0.4%-0.6%-0.8%
非控制權益(綜合損益)-1.4%-0.2%-0.1%-0.1%0.5%0.4%1.1%0.2%-0.7%-1.0%
基本每股盈餘0.0%0.0%0.0%0.0%0.1%0.0%0.0%-0.0%-0.0%-0.0%
稀釋每股盈餘0.0%0.0%0.0%0.0%0.0%0.0%0.0%-0.0%-0.0%-0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。